BR9605309A - Composições de derivados piperazina - Google Patents
Composições de derivados piperazinaInfo
- Publication number
- BR9605309A BR9605309A BR9605309A BR9605309A BR9605309A BR 9605309 A BR9605309 A BR 9605309A BR 9605309 A BR9605309 A BR 9605309A BR 9605309 A BR9605309 A BR 9605309A BR 9605309 A BR9605309 A BR 9605309A
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- piperazine derivatives
- piperazine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR19950000399 | 1995-01-11 | ||
| KR1019950043607A KR0162710B1 (ko) | 1995-01-10 | 1995-11-24 | 신규 피페라진 유도체 및 그 제조방법 |
| PCT/KR1996/000005 WO1996021648A1 (en) | 1995-01-11 | 1996-01-10 | New piperazine derivatives and methods for the preparation thereof and compositions containing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9605309A true BR9605309A (pt) | 1997-10-14 |
Family
ID=26630862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9605309A BR9605309A (pt) | 1995-01-11 | 1996-01-10 | Composições de derivados piperazina |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5780472A (pt) |
| EP (1) | EP0749425A1 (pt) |
| JP (1) | JP2978967B2 (pt) |
| CN (1) | CN1128139C (pt) |
| AU (1) | AU699619B2 (pt) |
| BR (1) | BR9605309A (pt) |
| CA (1) | CA2184919C (pt) |
| CZ (1) | CZ288002B6 (pt) |
| FI (1) | FI963566A (pt) |
| HU (1) | HUP9602489A3 (pt) |
| NO (1) | NO307459B1 (pt) |
| NZ (1) | NZ298499A (pt) |
| PL (1) | PL183865B1 (pt) |
| RO (1) | RO115159B1 (pt) |
| SK (1) | SK282252B6 (pt) |
| WO (1) | WO1996021648A1 (pt) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU226635B1 (en) * | 1995-01-23 | 2009-05-28 | Asubio Pharma Co | Piperidine and piperazine derivatives, medicines containing them as active ingredient and their use |
| ATE241600T1 (de) * | 1996-06-29 | 2003-06-15 | Samjin Pharm Co Ltd | Piperazin-derivate und verfahren zu ihrer herstellung |
| US6174905B1 (en) | 1996-09-30 | 2001-01-16 | Mitsui Chemicals, Inc. | Cell differentiation inducer |
| US6794392B1 (en) | 1996-09-30 | 2004-09-21 | Schering Aktiengesellschaft | Cell differentiation inducer |
| KR100420616B1 (ko) * | 1996-12-26 | 2004-05-17 | 동화약품공업주식회사 | 신규테레프탈산아미드유도체 |
| CN1129581C (zh) | 1998-09-22 | 2003-12-03 | 山之内制药株式会社 | 氰基苯基衍生物 |
| KR100396738B1 (ko) * | 1999-03-03 | 2003-09-03 | 삼진제약주식회사 | 피페라진 유도체 및 그 제조방법 |
| NZ523526A (en) | 2000-07-20 | 2004-10-29 | Neurogen Corp | Diaryl piperazines as capsaicin receptor ligands |
| DE10035908A1 (de) | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| US6432957B1 (en) * | 2001-06-29 | 2002-08-13 | Kowa Co., Ltd. | Piperazine derivative |
| JP2005502623A (ja) * | 2001-07-02 | 2005-01-27 | ノボ ノルディスク アクティーゼルスカブ | 置換ピペラジンおよびジアゼパン |
| MXPA04002423A (es) * | 2001-10-22 | 2004-05-31 | Pfizer Prod Inc | Derivados de piperazina con actividad antagonista del receptor ccr1. |
| KR20040068240A (ko) * | 2001-12-14 | 2004-07-30 | 노보 노르디스크 에이/에스 | 호르몬 민감성 리파아제의 활성을 감소시키기 위한 화합물및 그들의 사용 |
| ES2345044T3 (es) | 2002-02-01 | 2010-09-14 | Euro-Celtique S.A. | 2-piperazin-piridinas utiles para tratar el dolor. |
| RS114804A (en) | 2002-06-28 | 2006-12-15 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
| US7262194B2 (en) | 2002-07-26 | 2007-08-28 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
| US7157462B2 (en) | 2002-09-24 | 2007-01-02 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
| AU2004221812B2 (en) * | 2003-03-19 | 2010-02-18 | Exelixis Inc. | Tie-2 modulators and methods of use |
| HUE033441T2 (en) * | 2004-12-30 | 2017-11-28 | Janssen Pharmaceutica Nv | 4- (Benzyl) piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid hydrolase (phaha) for the treatment of anxiety, pain and other diseases |
| KR101063663B1 (ko) * | 2005-02-17 | 2011-09-07 | 아스텔라스세이야쿠 가부시키가이샤 | 피리딜 비방향족 질소 함유 헤테로환-1-카르복실산에스테르유도체 |
| PE20070099A1 (es) | 2005-06-30 | 2007-02-06 | Janssen Pharmaceutica Nv | N-heteroarilpiperazinil ureas como moduladores de la amida hidrolasa del acido graso |
| EP1923388A4 (en) | 2005-08-12 | 2011-03-09 | Takeda Pharmaceutical | BRAIN / NERVE CELL PROTECTION AND THERAPEUTIC FOR SLEEP DISORDERS |
| BRPI0717596B8 (pt) | 2006-10-18 | 2021-05-25 | Pfizer Prod Inc | compostos de éter biarílico uréia, seu uso e composição farmacêutica que os compreende |
| WO2008148851A1 (en) | 2007-06-08 | 2008-12-11 | Janssen Pharmaceutica N.V. | Piperidine/piperazine derivatives |
| CA2687912C (en) | 2007-06-08 | 2015-11-03 | Janssen Pharmaceutica N.V. | Piperidine/piperazine derivatives |
| JO2972B1 (en) | 2007-06-08 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Piperidine / piperazine derivatives |
| AU2008258487B2 (en) | 2007-06-08 | 2012-11-15 | Janssen Pharmaceutica N.V. | Piperidine/piperazine derivatives |
| MX2010003918A (es) * | 2007-10-10 | 2010-08-04 | Takeda Pharmaceutical | Compuesto de amida. |
| PE20100083A1 (es) | 2008-06-05 | 2010-02-17 | Janssen Pharmaceutica Nv | Combinaciones de drogas que comprenden un inhibidor de dgat y un agonista de ppar |
| US20120225097A1 (en) | 2009-11-12 | 2012-09-06 | Hawryluk Natalie A | Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah) |
| UA108233C2 (uk) * | 2010-05-03 | 2015-04-10 | Модулятори активності гідролази амідів жирних кислот | |
| WO2017083216A1 (en) * | 2015-11-12 | 2017-05-18 | Merck Sharp & Dohme Corp. | Cyanopyridine derivatives as liver x receptor beta agonists, compositions, and their use |
| US11970486B2 (en) * | 2016-10-24 | 2024-04-30 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
| WO2019084157A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES THEREOF |
| WO2022118966A1 (ja) * | 2020-12-04 | 2022-06-09 | 国立大学法人京都大学 | 細胞内への核酸分子取り込み促進剤、医薬組成物、及び新規化合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| OA04700A (fr) * | 1973-05-15 | 1980-07-31 | Rhone Poulenc Sa | Nouveaux dérivés de la naphtyridine et leur procédé de préparation. |
| WO1987007895A1 (en) * | 1986-06-23 | 1987-12-30 | The Upjohn Company | Androstane-type and cortical aminoesters |
| US4960776A (en) * | 1987-01-28 | 1990-10-02 | A. H. Robins Company, Inc. | 4-aryl-N-(alkylaminoalkyl, heterocyclicamino and heterocyclicamino)alkyl)-1-piperazinecarboxamides |
| JPH02142770A (ja) * | 1988-11-25 | 1990-05-31 | Shigeki Shin | ピペラジン系誘導体 |
| JPH03141258A (ja) * | 1989-10-25 | 1991-06-17 | Kowa Co | 新規なピペラジン誘導体 |
| DE4216364A1 (de) * | 1991-12-14 | 1993-11-25 | Thomae Gmbh Dr K | Neue Pyridylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| US5196428A (en) * | 1992-04-03 | 1993-03-23 | Bristol-Myers Squibb Company | Imidazo[4,5-b]qinolinyl oxy alkyl ureas |
-
1996
- 1996-01-10 CA CA002184919A patent/CA2184919C/en not_active Expired - Lifetime
- 1996-01-10 US US08/676,174 patent/US5780472A/en not_active Expired - Lifetime
- 1996-01-10 EP EP96900459A patent/EP0749425A1/en not_active Withdrawn
- 1996-01-10 HU HU9602489A patent/HUP9602489A3/hu unknown
- 1996-01-10 BR BR9605309A patent/BR9605309A/pt unknown
- 1996-01-10 CZ CZ19962960A patent/CZ288002B6/cs not_active IP Right Cessation
- 1996-01-10 PL PL96316613A patent/PL183865B1/pl unknown
- 1996-01-10 WO PCT/KR1996/000005 patent/WO1996021648A1/en not_active Application Discontinuation
- 1996-01-10 AU AU44007/96A patent/AU699619B2/en not_active Expired
- 1996-01-10 CN CN96190006A patent/CN1128139C/zh not_active Expired - Lifetime
- 1996-01-10 JP JP8521570A patent/JP2978967B2/ja not_active Expired - Lifetime
- 1996-01-10 RO RO96-01781A patent/RO115159B1/ro unknown
- 1996-01-10 SK SK889-96A patent/SK282252B6/sk unknown
- 1996-01-10 NZ NZ298499A patent/NZ298499A/en not_active IP Right Cessation
- 1996-09-10 NO NO963792A patent/NO307459B1/no unknown
- 1996-09-10 FI FI963566A patent/FI963566A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5780472A (en) | 1998-07-14 |
| HUP9602489A2 (en) | 1997-08-28 |
| FI963566A0 (fi) | 1996-09-10 |
| SK88996A3 (en) | 1997-05-07 |
| CZ296096A3 (en) | 1997-02-12 |
| HU9602489D0 (en) | 1996-11-28 |
| AU699619B2 (en) | 1998-12-10 |
| NO307459B1 (no) | 2000-04-10 |
| NO963792L (no) | 1996-11-11 |
| SK282252B6 (sk) | 2001-12-03 |
| NZ298499A (en) | 1998-01-26 |
| PL183865B1 (pl) | 2002-07-31 |
| NO963792D0 (no) | 1996-09-10 |
| JP2978967B2 (ja) | 1999-11-15 |
| AU4400796A (en) | 1996-07-31 |
| CN1128139C (zh) | 2003-11-19 |
| CA2184919C (en) | 2000-03-14 |
| CN1145620A (zh) | 1997-03-19 |
| RO115159B1 (ro) | 1999-11-30 |
| PL316613A1 (en) | 1997-01-20 |
| CZ288002B6 (cs) | 2001-03-14 |
| JPH09511764A (ja) | 1997-11-25 |
| FI963566A (fi) | 1996-09-10 |
| HUP9602489A3 (en) | 1998-01-28 |
| EP0749425A1 (en) | 1996-12-27 |
| CA2184919A1 (en) | 1996-07-18 |
| WO1996021648A1 (en) | 1996-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9605309A (pt) | Composições de derivados piperazina | |
| BR9507179A (pt) | Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena | |
| BR9611130A (pt) | Derivados de 3-aril-5-halógeno-pirona | |
| BR9509200A (pt) | Composição de matéria | |
| BR9510256A (pt) | Derivados de ácido 3-aril-tetrônico | |
| PT1093815E (pt) | Formulacao oral de 2-metil-tieno-benzodiazepina | |
| ITMI951020A0 (it) | Derivati di diarildiammine | |
| FI974241A0 (fi) | BPM-15 -koostumukset | |
| PT833828E (pt) | Derivados de rapamicina | |
| BR9712037A (pt) | Derivados de piperazina | |
| BR9611834A (pt) | Derivados de oximetóxi-3-aril-pirona | |
| BR9605434A (pt) | Derivados de purin-6-ona | |
| NO981568D0 (no) | Randtennings-tennsatssammensetninger | |
| PT1014987E (pt) | Composicoes orais de levosimendano | |
| DE69617029D1 (de) | Organoton-zusammensetzungen | |
| PT921125E (pt) | Derivados de 1,38-triaza-espiro 4,5 decan-4-ona | |
| KR970000222A (ko) | 팩리택셀 유도체의 전구약물 | |
| ITMI941463A0 (it) | Derivati eterociclo-condensatori di morfinoidi | |
| BR9610597A (pt) | Derivados de diarilalcenilamina | |
| EE9900206A (et) | N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid | |
| BR9607046A (pt) | Derivados de 3-pirrolidiliden-2-ona-cefalosporinas | |
| DE69603228T2 (de) | Aluminoxanate-Zusammensetzungen | |
| DE69625500T2 (de) | Achselzusammensetzungen | |
| ATE206150T1 (de) | Farbstoffstabilisierte zusammensetzungen | |
| BR9609723A (pt) | Derivados da tricetona |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |